|Original language||English (US)|
|Number of pages||3|
|Journal||JAMA - Journal of the American Medical Association|
|State||Published - May 4 2021|
ASJC Scopus subject areas
Access to Document
Other files and links
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients. / Boyarsky, Brian J.; Werbel, William A.; Avery, Robin K.; Tobian, Aaron A.R.; Massie, Allan B.; Segev, Dorry L.; Garonzik-Wang, Jacqueline M.In: JAMA - Journal of the American Medical Association, Vol. 325, No. 17, 04.05.2021, p. 1784-1786.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients
AU - Boyarsky, Brian J.
AU - Werbel, William A.
AU - Avery, Robin K.
AU - Tobian, Aaron A.R.
AU - Massie, Allan B.
AU - Segev, Dorry L.
AU - Garonzik-Wang, Jacqueline M.
N1 - Funding Information: Funding/Support: This work was supported by the Ben-Dov family; grants F32DK124941 (awarded to Dr Boyarsky), K01DK101677 (to Dr Massie), and K23DK115908 (to Dr Garonzik-Wang) from the National Institute of Diabetes and Digestive and Kidney Diseases; grant gSAN-201C0WW (to Dr Werbel) from the Transplantation and Immunology Research Network of the American Society of Transplantation; and grant K24AI144954 (to Dr Segev) from the National Institute of Allergy and Infectious Diseases. Funding Information: Conflict of Interest Disclosures: Dr Avery reported receiving grant support from Aicuris, Astellas, Chimerix, Merck, Oxford Immunotec, Qiagen, and Takeda/Shire. Dr Segev reported serving as a consultant to and receiving honoraria for speaking from Sanofi, Novartis, CSL Behring, Jazz Pharmaceuticals, Veloxis, Mallincrodt, and Thermo Fisher Scientific. No other disclosures were reported.
PY - 2021/5/4
Y1 - 2021/5/4
UR - http://www.scopus.com/inward/record.url?scp=85102479199&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102479199&partnerID=8YFLogxK
U2 - 10.1001/jama.2021.4385
DO - 10.1001/jama.2021.4385
M3 - Letter
C2 - 33720292
AN - SCOPUS:85102479199
VL - 325
SP - 1784
EP - 1786
JO - JAMA - Journal of the American Medical Association
JF - JAMA - Journal of the American Medical Association
SN - 0098-7484
IS - 17